Not Yet RecruitingNot Applicable

Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status

165 participantsStarted 2025-09

Plain-language summary

VKA in RHD patients with MHV: our current status

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Confirmed presence of a mechanical heart valve. * Aged ≥18 years Exclusion Criteria: * Pregnancy. * Active bleeding disorders. * Severe liver/kidney disease (if affecting anticoagulation).

What they're measuring

Time in therapeutic range (TTR) for warfarin.

Timeframe: Baseline

2. Correlation Between TTR and Patient-Specific Factors

Timeframe: Baseline

Trial details

NCT IDNCT07146282

SponsorAhmed Hassan Rostom Ibrahim

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-09

Contact for this trial

Ahmed Hassan Rostom, Master

+201122713232 ahmedrostom112@gmail.com

View on ClinicalTrials.gov More Rheumatic Heart Disease trials